Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Cost‐Effectiveness of Donanemab for Early Alzheimer Disease in Australia
Cost‐Effectiveness of Donanemab for Early Alzheimer Disease in Australia
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Lan Gao
,
Rosie Watson
,
Nawaf Yassi
Format:
Artículo Open Access
Published:
Wiley
2026
Subjects:
Medical Journal of Australia
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://onlinelibrary.wiley.com/doi/10.5694/mja2.70186
Similar Items
Contextualising the benefits and risks of anti‐amyloid therapy for patients with Alzheimer disease and their care team
by: Oneil G Bhalala, et al.
Published: (2024)
Chronic Kidney Disease and Unmet Needs for Comprehensive Rehabilitation in Australia
by: Limy Wong, et al.
Published: (2026)
Uptake and Costs of the 60‐Day Dispensing Policy for Antihypertensive Medicines in Australia: A Mixed Methods Study
by: Tian Wang, et al.
Published: (2026)
Inequity Is Our Biggest Killer: Looking Upstream to Tackle the Burden of Disease in Australia
by: Saman Khalatbari‐Soltani, et al.
Published: (2025)
Socio‐Economic Position and the Prevalence of Ten Chronic Diseases in Australia, 2021: A Whole of Population Census Data Analysis
by: Fei Zhang, et al.
Published: (2026)